Search Results 881-890 of 16214 for chemoprevention
About this study. This study will test whether immune functions in individual cancer patients can be characterized in a quantitative manner using new ...
Below are current clinical trials. 2790 studies in Mayo Clinic Comprehensive Cancer Center — Research (all studies, either open or closed). Filter this list of ...
Chemoprevention agents for melanoma: A path forward into phase 3 clinical trials. Cancer. 2019 Jan 1; 125 (1):18-44 Epub 2018 Oct 03. View PubMed; Tolkachjov ...
To assess the safety and tolerability at increasing dose levels of HPN536 in successive cohorts of patients with epithelial ovarian, fallopian tube, ...
The primary purpose of this study is to assess the clinical activity of AL101 using radiographic assessments and Response Evaluation Criteria in Solid Tumors ( ...
RATIONALE: Dasatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as bevacizumab, ...
The purpose of this study is to determine the feasibility and benefit of a patient-reported outcomes quality of life tool for hematology and medical oncology.
Biomedical discovery research spans diseases, affecting the future of care in cancer, fibrosis, the immune system and metabolism, to name a few. The following ...
The Copland Cancer Biology and Translational Research Lab at Mayo Clinic has created novel SCD1-specific inhibitors that are being developed for cancer ...
The purpose of this study is to compare the effectiveness of RO7198457 versus watchful waiting in patients with circulating tumor DNA (ctDNA) positive, ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Thanks to generous benefactors, your gift today can have 5X the impact to advance AI innovation at Mayo Clinic.